Key points are not available for this paper at this time.
Analyses of at-risk cognitively normal populations suggest that we can reliably measure the first signs of cognitive decline with the ADCS-PACC. These analyses also suggest the feasibility of secondary prevention trials.
Donohue et al. (Mon,) studied this question.